DA
IMUX icon

Denali Advisors’s Immunic IMUX Stock Holding History

Denali Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,700
Closed -$25K – 478
2023
Q3 		$25K Hold
1,700
– – 0.01% 328
2023
Q2 		$42.7K Hold
1,700
– – 0.02% 295
2023
Q1 		$25.3K Hold
1,700
– – 0.01% 278
2022
Q4 		$23.8K Hold
1,700
– – 0.01% 292
2022
Q3 		$54K Buy
+1,700
New +$71.2K 0.03% 203

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Denali Advisors's IMUX Position: Q4 2023 in Review

Denali Advisors sold out of Immunic (IMUX) in Q4 2023, closing a stake of 1,700 shares — an estimated $25K sold.

Denali Advisors first reported a position in IMUX in Q3 2022 and held it in 5 quarters. The position peaked at $54K in Q3 2022. 49 funds tracked by Wall St. Rank hold IMUX as of Q4 2023.

  • Denali Advisors reported no remaining Immunic position as of Q4 2023 after selling out during the quarter.
  • Denali Advisors sold 1,700 Immunic shares in Q4 2023, an estimated $25K.
  • Denali Advisors first reported a position in Immunic in Q3 2022 and held it in 5 quarters.
  • Denali Advisors's Immunic position peaked at $54K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Immunic as of Q4 2023.

Based on Denali Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.